Acute Upper Airway Disease in Children with the Omicron (B.1.1.529) Variant of SARS-CoV-2 - A Report from the US National COVID Cohort Collaborative

Blake Martin; Peter E. Dewitt; Seth Russell; L. Nelson Sanchez-Pinto; Melissa A. Haendel; Richard Moffitt; Tellen D. Bennett

doi:10.1001/jamapediatrics.2022.1110

Acute Upper Airway Disease in Children with the Omicron (B.1.1.529) Variant of SARS-CoV-2 - A Report from the US National COVID Cohort Collaborative

Blake Martin, Peter E. Dewitt, Seth Russell, L. Nelson Sanchez-Pinto, Melissa A. Haendel, Richard Moffitt, Tellen D. Bennett

Research output: Contribution to journal › Letter › peer-review

29 Scopus citations

Original language	English (US)
Pages (from-to)	819-821
Number of pages	3
Journal	JAMA Pediatrics
Volume	176
Issue number	8
DOIs	https://doi.org/10.1001/jamapediatrics.2022.1110
State	Published - Aug 2022
Externally published	Yes

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health

Access to Document

10.1001/jamapediatrics.2022.1110

Cite this

@article{6e9a32f10afc4d1c863a0a928604392a,

title = "Acute Upper Airway Disease in Children with the Omicron (B.1.1.529) Variant of SARS-CoV-2 - A Report from the US National COVID Cohort Collaborative",

author = "Blake Martin and Dewitt, {Peter E.} and Seth Russell and Sanchez-Pinto, {L. Nelson} and Haendel, {Melissa A.} and Richard Moffitt and Bennett, {Tellen D.}",

note = "Funding Information: Funding/Support: This study was funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD105939-01S1). Additionally, the analyses described in this publication were conducted with data or tools accessed through the NCATS N3C Data Enclave (covid.cd2h.org/enclave) and supported by NCATS U24 TR002306. This research was possible because of the patients whose information is included within the data from participating organizations (covid.cd2h.org/dtas) and the organizations and scientists (covid.cd2h.org/duas) who have contributed to the ongoing development of this community resource (https:// doi.org/10.1093/jamia/ocaa196). Funding Information: Conflict of Interest Disclosures: Dr Martin reports grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development during the conduct of the study and from Thrasher Research Fund Early Career Award outside the submitted work. Drs Sanchez-Pinto and Moffitt report grants from National Institutes of Health during the conduct of the study. Dr Bennett reports grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development during the conduct of the study and grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Heart, Lung, and Blood Institute, and the National Center for Advancing Translational Sciences outside the submitted work. No other disclosures were reported.",

year = "2022",

month = aug,

doi = "10.1001/jamapediatrics.2022.1110",

language = "English (US)",

volume = "176",

pages = "819--821",

journal = "JAMA Pediatrics",

issn = "2168-6203",

publisher = "American Medical Association",

number = "8",

}

TY - JOUR

T1 - Acute Upper Airway Disease in Children with the Omicron (B.1.1.529) Variant of SARS-CoV-2 - A Report from the US National COVID Cohort Collaborative

AU - Martin, Blake

AU - Dewitt, Peter E.

AU - Russell, Seth

AU - Sanchez-Pinto, L. Nelson

AU - Haendel, Melissa A.

AU - Moffitt, Richard

AU - Bennett, Tellen D.

N1 - Funding Information: Funding/Support: This study was funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD105939-01S1). Additionally, the analyses described in this publication were conducted with data or tools accessed through the NCATS N3C Data Enclave (covid.cd2h.org/enclave) and supported by NCATS U24 TR002306. This research was possible because of the patients whose information is included within the data from participating organizations (covid.cd2h.org/dtas) and the organizations and scientists (covid.cd2h.org/duas) who have contributed to the ongoing development of this community resource (https:// doi.org/10.1093/jamia/ocaa196). Funding Information: Conflict of Interest Disclosures: Dr Martin reports grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development during the conduct of the study and from Thrasher Research Fund Early Career Award outside the submitted work. Drs Sanchez-Pinto and Moffitt report grants from National Institutes of Health during the conduct of the study. Dr Bennett reports grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development during the conduct of the study and grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Heart, Lung, and Blood Institute, and the National Center for Advancing Translational Sciences outside the submitted work. No other disclosures were reported.

PY - 2022/8

Y1 - 2022/8

UR - http://www.scopus.com/inward/record.url?scp=85128348782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85128348782&partnerID=8YFLogxK

U2 - 10.1001/jamapediatrics.2022.1110

DO - 10.1001/jamapediatrics.2022.1110

M3 - Letter

C2 - 35426941

AN - SCOPUS:85128348782

SN - 2168-6203

VL - 176

SP - 819

EP - 821

JO - JAMA Pediatrics

JF - JAMA Pediatrics

IS - 8

ER -

Acute Upper Airway Disease in Children with the Omicron (B.1.1.529) Variant of SARS-CoV-2 - A Report from the US National COVID Cohort Collaborative

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this